Scilex Holding (SCLX) Current Leases (2021 - 2026)
Scilex Holding (SCLX) posted quarterly Current Leases of $1.7 million for Q1 2026, up 132.84% year-over-year from $740000.0 in Q1 2025, and down 0.58% on a QoQ basis from $1.7 million in Q4 2025.
Scilex Holding (SCLX) Current Leases (2021 - 2026) Analysis & Trends
Scilex Holding (SCLX) has reported Current Leases for 6 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases rose 132.84% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 132.84% YoY), while the FY2025 annual figure was $1.7 million, up 142.72% from the prior year.
- Current Leases came in at $1.7 million for Q1 2026 at Scilex Holding, down from $1.7 million in the prior quarter.
- The five-year high for Current Leases was $1.7 million in Q4 2025, with the low at $688000.0 in Q3 2024.
- Average Current Leases over 5 years is $888142.9, with a median of $763500.0 recorded in 2023.
- Across the five-year window, Current Leases dropped 12.58% in 2024 and jumped 142.72% in 2025, its largest moves.
- Year by year, Current Leases stood at $745000.0 in 2022, then gained by 1.88% to $759000.0 in 2023, then dropped by 5.93% to $714000.0 in 2024, then soared by 142.72% to $1.7 million in 2025, then decreased by 0.58% to $1.7 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $1.7 million, $1.7 million, and $796000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | - |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | - |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | 271.00 Mn |
| 10 | Scilex Holding | 54.30 Mn | -95.62 Mn | 4.15 Mn | 1.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.72 Mn |
| Dec 31, 2025 | 1.73 Mn |
| Sep 30, 2025 | 796,000.00 |
| Jun 30, 2025 | 768,000.00 |
| Mar 31, 2025 | 740,000.00 |
| Dec 31, 2024 | 714,000.00 |
| Sep 30, 2024 | 688,000.00 |
| Jun 30, 2024 | 701,000.00 |
| Mar 31, 2024 | 731,000.00 |
| Dec 31, 2023 | 759,000.00 |
| Sep 30, 2023 | 787,000.00 |
| Jun 30, 2023 | 776,000.00 |
| Mar 31, 2023 | 773,000.00 |
| Dec 31, 2022 | 745,000.00 |
| Dec 31, 2021 | 500,000.00 |